KS
Karen Soares
Chief Legal Officer

Karen Soares insider trades: Clover Health Investments (CLOV) stock sales

Chief Legal Officer, Clover Health Investments Last trade Oct 20, 2026 41 Form 4 filings
$495K
Sold, last 12 months
6 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2025
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Karen reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 20, 2026CLOV↓ Sell10b5-1$90K
Oct 15, 2026CLOV↓ Sell$69K
Sep 15, 2026CLOV↓ Sell$33K
Jul 20, 2026CLOV↓ Sell10b5-1$233K
Jul 15, 2026CLOV↓ Sell$49K
Jun 15, 2026CLOV↓ Sell$22K
Mar 6, 2025CLOV↓ Sell$200K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CLOV insiders

Open-market trades in the last 12 months

About Karen Soares's insider trades

Karen Soares is Chief Legal Officer at Clover Health Investments (CLOV). Since Mar 6, 2025, Karen has reported no open-market purchases and 7 sales worth $695K on SEC Form 4. In the last 12 months: 6 sales ($495K).

2 sales (47% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include shares withheld for taxes (29 filings), grants and awards (6 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLOV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.